09:52 AM EST - Acerus Pharmaceuticals Corporation : Reported its results for the year ended December 31, 2015. All amounts are in U.S. dollars. Total product revenue was $9.0 million for full year 2015. Adjusted EBITDA showed a loss of $0.9 million. Acerus Pharmaceuticals Corporation
shares T.ASP are trading unchanged at $0.10.
